3E BIOVENTURES
3E Bioventures Capital is a healthcare focused venture investment fund. The core 3E investment team members are all trained in biomedical fields, with healthcare industry experience and years of successful investment or entrepreneurship experience in China. The 3E team combines good global industry perspectives with practical on the ground China experiences, the team’s past investment portfolio companies cover areas such as drug, device, diagnostics, healthcare IT and medical services. 3E Biov... entures Capital currently manages both RMB and US Dollar funds, investing in early and growing stage companies in China and overseas. They believe in the huge industry growth and significant investment opportunities in China healthcare space for the next 10 to 20 years. They aim to leverage their healthcare expertise and experience to ride this historic opportunity, to help build successful healthcare ventures and technologies, to generate good return for their investors, and at the same time, to build 3E Bioventures into a significant international healthcare investment brand.
3E BIOVENTURES
Social Links:
Founded:
2015-01-01
Status:
Active
Contact:
(810) 123 4567
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apache GlobalSign GlobalSign Domain Verification Alibaba HiChina DNS
Similar Organizations
Quest Ventures
Quest Ventures is a top venture capital firm in Asia.
Samsung Ventures
Samsung Ventures is a venture capital firm specializing in investments in start-up companies.
Side Door Ventures
Side Door Ventures is a venture capital firm specializing in pre-seed through Series B startup investments.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-15 | Regenacy Pharmaceuticals | 3E Bioventures investment in Series B - Regenacy Pharmaceuticals | 9.3 M USD |
| 2022-03-03 | CytoNiche | 3E Bioventures investment in Series B - CytoNiche | 300 M CNY |
| 2022-02-03 | Dewpoint Therapeutics | 3E Bioventures investment in Series C - Dewpoint Therapeutics | 150 M USD |
| 2022-01-18 | Dermaliq Therapeutics | 3E Bioventures investment in Series A - Dermaliq Therapeutics | 15 M USD |
| 2021-12-29 | Zhengli Technology | 3E Bioventures investment in Venture Round - Zhengli Technology | N/A |
| 2021-12-09 | Boaoxin | 3E Bioventures investment in Venture Round - Boaoxin | 200 M CNY |
| 2021-12-01 | ITabMed | 3E Bioventures investment in Series A - ITabMed | 20 M USD |
| 2021-11-16 | Novlead Biotech | 3E Bioventures investment in Series B - Novlead Biotech | 120 M CNY |
| 2021-09-13 | Alebund Pharmaceuticals | 3E Bioventures investment in Series B - Alebund Pharmaceuticals | 54.5 M USD |
| 2021-08-29 | NeuralGalaxy | 3E Bioventures investment in Series A - NeuralGalaxy | 500 M CNY |
More informations about "3E Bioventures"
3E Bioventures - Crunchbase Investor Profile
3E Bioventures Capital is a healthcare focused venture investment fund. The core 3E investment team members are all trained in biomedical fields, with healthcare industry experience and years of successful investment or entrepreneurship …See details»
3E Bioventures Capital——Expertise, Efficiency & Execution
3E Bioventures takes on a science-driven, entrepreneur-friendly investment philosophy by working closely with companies and research institutions to develop drugs or products that …See details»
3E Bioventures - LinkedIn
BIO is the largest global organization in biotechnology industry. It holds its annual confetence conference in San Diego and Boston every other year alternatively. ... 3E Bioventures Capital is a ...See details»
Portfolio - 3E Bioventures Capital——Expertise, Efficiency
3E Bioventures Capital is a healthcare focused fund dedicated to investing in frontier technologies. We mainly invest in two areas: innovative therapeutic drugs and disruptive cross …See details»
3E Bioventures - Investments, Portfolio & Company Exits
3E Bioventures 's most notable exits include Cytek Biosciences, C4 Therapeutics, and Biocytogen. Which industries has this organization had the most exits in? Show . Cytek …See details»
3E Bioventures Capital investment portfolio - PitchBook
Apr 27, 2023 3E Bioventures Capital General Information Company Description. Founded in 2015, 3E Bioventures Capital is a venture capital firm based in Palo Alto, California. The firm prefers to invest in companies operating in the life …See details»
3E Bioventures (China) investment portfolio | PitchBook
Aug 1, 2022 3E Bioventures (China) General Information Company Description. Founded in 2015, 3E Bioventures is a venture capital firm based in Beijing, China. The firm prefers to invest in seed-stage, early-stage, and later-stage …See details»
3E Bioventures - Funding, Financials, Valuation & Investors
3E Bioventures has raised a total of $200M in a single venture fund, 3E Bioventures Capital II. This fund was announced on Jun 13, 2019 and raised a total of . obfuscated. obfuscated. …See details»
3E Bioventures Capital Fund II: Performance - PitchBook
Jan 1, 2018 3E Bioventures Capital Fund II Investments (4) 3E Bioventures Capital Fund II has made a total of 4 investments. Its most recent deal was a with Bayland Scientific for .The deal …See details»
3E Bioventures - Overview, News & Similar companies - ZoomInfo
Explore Complete Organization Structure. Is 3E Bioventures your ideal costumer? Let us give you the heads up on whether it's a good time to reach out ... Sophia Innovation Capital, Plaisance …See details»
Biosion, Inc. Completed Pre-B+ Round Financing to Accelerate the ...
Dec 10, 2021 About 3E Bioventures Capital. 3E Bioventures Capital is dedicated to investing in cutting-edge life sciences and biomedical technologies, with a focus on breakthrough first-in …See details»
3E Bioventures - Updates, News, Events, Signals & Triggers
3E Bioventures is a venture capital firm specializing in growth capital. 3E Bioventures invests in early to late-stage biotechnology and healthcare companies, focusing on science and …See details»
Regenacy Announces the Formation of a Joint Venture with 3E …
Dec 21, 2020 3E Bioventures Capital is a healthcare venture capital firm, dedicated to investing in cutting-edge life sciences and biomedical technologies, with a focus on breakthrough first-in …See details»
3E Bioventures Capital III: Fund Performance - PitchBook
3E Bioventures Capital III General Information Description. 3E Bioventures Capital III is a venture capital fund managed by 3E Bioventures Capital. The fund is located in Palo Alto, California.See details»
Rapafusyn Pharmaceuticals Secures $28 Million Series A to …
Jun 20, 2024 About 3E Bioventures. 3E Bioventures Capital is a life science focused VC fund, actively investing in global leading health innovators, investing in Biotech (new drugs, new …See details»
List of top 3E Bioventures Portfolio Companies - Crunchbase
Jul 18, 2015 3E Bioventures is a venture capital firm specializing in growth capital. This list of organizations invested in by 3E Bioventures provides data on their funding history, investment …See details»
Cullgen Closes $50 Million Series B Investment to Advance …
Feb 25, 2021 In addition to receiving funding from existing Cullgen investors, five new prominent international venture capital firms also participated in the financing, including the lead investor, …See details»
3E Bioventures exercises $7M warrant as part of Series A financing ...
Sep 20, 2022 3E Bioventures exercises $7M warrant as part of Series A financing; bringing Rapafusyn's total funding raised to $30M. Corporate Sam Hong September 20, 2022. …See details»
3E Bioventures - Contacts, Employees, Board Members
3E Bioventures is a venture capital firm specializing in growth capital.See details»